Evidence map›Paper›PMID 36399162›Full record

ReviewCell and tissue research2023

Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.

Angélique Igel, Basile Fornara, Human Rezaei, Vincent Béringue

Abstract readReview
In one paragraph

Review in Cell and tissue research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Depleting prion protein using splice-switching small molecules.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. BSE risk posed by ruminant collagen and gelatine derived from bones.EFSA journal. European Food Safety Authority · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. New developments in prion disease research.Cell and tissue research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Angélique IgelUniversité Paris-Saclay, INRAE, UVSQ, VIM, 78350, Jouy-en-Josas, France.
Basile FornaraUniversité Paris-Saclay, INRAE, UVSQ, VIM, 78350, Jouy-en-Josas, France.
Human RezaeiUniversité Paris-Saclay, INRAE, UVSQ, VIM, 78350, Jouy-en-Josas, France. human.rezaei@inrae.fr.
Vincent BéringueUniversité Paris-Saclay, INRAE, UVSQ, VIM, 78350, Jouy-en-Josas, France. vincent.beringue@inrae.fr.ORCID http://orcid.org/0000-0001-6706-5712

Funding

Agence Nationale de la Recherche ANR-21-CE15-0011-01DIM One-health (FR) PrionDiffINRAE - DigitBIO PrionDif
6 · The paper itself

Abstract

Prions are proteinaceous pathogens responsible for a wide range of neurodegenerative diseases in animal and human. Prions are formed from misfolded, ß-sheet rich, and aggregated conformers (PrP

Indexed as

Neurodegenerative DiseasesPrion DiseasesPrionsAnimalsHumansPrion ProteinsPrion ProteinsPrionsAutocatalyticConformationPrionsPrPQuasispeciesTransgenic mice

Identifiers

PMID36399162
PMCPMC10113350

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.